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ABSTRACT
Objective: To assess the impact of the percent of resected tissue on the improvement of urinary symptoms.
Materials and Methods: The study included a prospective analysis of 88 men with benign prostatic hyperplasia. Patients 
were divided in three groups according to the percent of resected tissue: Group 1 < 30%; Group 2, 30% to 50%; and Group 
3, > 50%. Each patient was re-evaluated 3 months after surgery. We assessed the international prostatic symptom score, 
nocturia and serum prostate specific antigen levels.
Results: All patients presented a significant decrease on mean International Prostate System Score (IPSS) (23 to 5.9), Quality 
of Life (QoL) (4.9 to 1.0) and nocturia (3.2 to 1.9). Variation in the IPSS was 16.7, 16.6 and 18.4 for patients from Group 
1, 2 and 3 respectively (P = 0.504). Although the three groups presented a significant decrease in QoL, patients in Group 
3 presented a significantly greater decrease when compared to Group 1. Variation in QoL was 3.1, 3.9 and 4.2 for patients 
from Group 1, 2 and 3 respectively (p = 0.046). There was no significant difference in nocturia variation according to the 
percent of resected tissue (p = 0.504). Median pre and postoperative PSA value was 3.7 and 1.9 ng/mL respectively. Patients 
from Group 1 did not show a significant variation (p = 0.694). Blood transfusions were not required in any group.
Conclusions: Resection of less than 30% of prostatic tissue seems to be sufficient to alleviate lower urinary tract symptoms 
related to benign prostate hyperplasia. However, these patients may not show a significant decrease in serum PSA level.
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INTRODUCTION
 Benign prostatic hyperplasia (BPH) is the 
most common benign neoplasm in men. By the age 
of 60, half of all men have histological evidence of 
BPH and virtually all men have it by the age of 80 
(1). Additionally, in a recent retrospective study of 
more than one million men 50 years of age or older in 
a managed care population from United States, BPH 
was among the four  prevalent diagnoses (2).
 Despite the development of new minimally 
invasive methods, transurethral resection of the pros-
 Clinical Urology 
tate (TURP) remains the gold standard surgical treat-
ment for lower urinary tract symptoms (LUTS) related 
to BPH, with more than 90% of the patients reporting 
normal or improved voiding, after 10-year follow-up 
period (3,4). The recommended technique of TURP 
consists of complete removal of all adenomatous tis-
sue inside the surgical capsule (5). However, compli-
cation rates seem to be related to resection time and 
the amount of resected tissue (6), and historical data 
has shown that the amount of resected tissue during 
TURP has decreased significantly over the last 10 
years (7,8).
doi: 10.1590/S1677-55382009000600007 
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 In fact, to date there is no consensus regard-
ing what amount of tissue should be resected during 
TURP. While some authors have suggested that bet-
ter clinical results after TURP may correlate with 
the completeness of the resection of the obstructing 
adenoma (9,10), others have shown that partial 
resection produces short-term functional results 
comparable to those of standard TURP (11,12). The 
aim of this study was to evaluate the impact of the 
percent of resected tissue (PRT) during TURP on the 
short-term clinical outcome of patients with LUTS 
due to BPH.
MATERIALS AND METHODS
 The study comprised a prospective analysis 
of a cohort of 144 consecutive men who underwent 
TURP for treatment of LUTS due to BPH between 
February 2006 and June 2007. After exclusion of 56 
cases that were treated for urinary retention, the final 
sample comprised of 88 patients. All these patients 
had moderate or severe LUTS that were refractory 
to medical treatment and were at least dissatisfied 
with their urinary condition. Patients with neurogenic 
bladder or prostatic carcinoma were not considered 
for analysis.
 All patients underwent detailed physical ex-
amination including digital rectal examination, blood 
chemistry, urine analysis and serum prostate specific 
antigen (PSA) test. For assessment of LUTS and QoL, 
we used the International Prostate Symptom Score 
(IPSS) (13) and its appended 8th question related to 
quality of life (QoL). PSA behavior was also analyzed. 
Prostate volume was measured through abdominal 
ultrasound and estimated as length x width x height 
x 0.52. All patients were operated on under spinal 
anesthesia with a 24-French Storz continuous-flow 
resectoscope and a standard loop. The resected tissue 
was systematically weighed immediately after the 
surgical procedure. Perioperative complications were 
recorded if present. The urethral Foley catheter was 
removed from all patients 48 hours after TURP and 
they were discharged home on the third postoperative 
day. They were re-evaluated at 3 months for LUTS, 
QoL, nocturia and serum PSA levels.
 The PRT was calculated as the resected tissue 
weight divided by the preoperative ultrasound prostate 
volume measurement x 100. Patients were divided in 
three groups according to the PRT: Group 1 < 30%; 
Group 2 = 30% to 50%; and Group 3 > 50%. Table-1 
shows the baseline demographic characteristics of the 
three study groups. Mean patient age, IPSS, nocturia, 
duration of symptoms, prostate weight and serum PSA 
levels were similar between the groups. Regarding 
QoL, patients from Group 3 presented a marginally 
significant higher mean score when compared to 
patients from Group 1.
Table 1 – Baseline characteristics of patients according to the percent of resected tissue.
< 30%
(n = 23)
30 to 50%
(n = 43)
> 50%
(n = 22)
p Value
Age 69.4 ± 9.4 66.1 ± 8.3 68.7 ± 7.7 0.254
Preoperative prostate weight (g)   53.0 ± 14.8   53.8 ± 13.5   53.1 ± 13.0 0.971
Mean IPSS 24.4 ± 6.6 22.8 ± 6.0 24.7 ± 5.7 0.418
Mean QoL score   4.4 ± 0.9   4.9 ± 1.0   5.2 ± 0.9 0.056
Mean nocturia   3.5 ± 1.4   2.9 ± 1.3   3.4 ± 1.9 0.273
Median preoperative PSA
(min – max)
3.0
(0.5 - 10.0)
3.7
(0.8 - 34.0)
4.0
(1.4 - 14.0)
0.136
Median duration of symptoms
(min – max days)
3.0
(1 - 10)
3.0
(1 - 15)
2.5
(1 - 10)
0.719
IPSS = international prostate symptom score; QoL = quality of life.
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 Since for the patient the most important 
outcome parameter is satisfaction with symptomatic 
improvement, primary end point was a change in QoL 
score according to the PRT. Secondary end points 
were a change in IPSS, nocturia or serum PSA levels. 
For statistical analysis we used the ANOVA test. Sta-
tistical analysis was performed using the SPSS 12.0 
for Windows software and significance was set as p 
≤ 0.05.
RESULTS
 Mean resected tissue weight was 12.4 ± 4.4, 
22.3 ± 7.4 and 33.8 ± 6.1 grams for patients from 
group 1, 2 and 3 respectively (p < 0.001). Mean pre 
and postoperative QoL score was 4.9 ± 1.0 and 1.0 ± 
1.0 respectively. The three groups showed a signifi-
cant improvement in QoL (mean 3.7 ± 0.3; p < 0.001), 
however, patients from Group 3 when compared to 
patients from Group 1 presented a significantly greater 
decrease (p = 0.046). Variation in QoL was 3.1 ± 0.3, 
3.9 ± 0.2 and 4.2 ± 0.3 for patients from group 1, 2 
and 3 respectively (Figure-1).
 Mean pre and postoperative IPSS was 23.0 ± 
5.6 and 5.9 ± 4.6 respectively. There was a significant 
decrease in IPSS among the three study groups (mean 
17.1 ± 0.7; p < 0.001), but despite a slight greater 
variation among patients from group 3, no significant 
statistical difference in the IPSS variation according to 
the PRT was observed (p = 0.561). Variation in IPSS 
was 16.7, 16.6 and 18.4 for patients from group 1, 2 
and 3 respectively (Figure-2).
 Mean pre and postoperative nocturia was 3.2 
± 1.5 and 1.9 ± 1.3 respectively. Again, the 3 groups 
presented a significant decrease in nocturia (mean 1.4 
± 0.2; p < 0.001). There was no significant difference 
in nocturia variation according to the PRT (p = 0.504). 
Postoperative nocturia was 1.8 ± 1.3, 1.7 ± 1.4 and 2.0 
± 1.4 for patients from Group 1, 2 and 3 respectively 
(Figure-3).
 Median pre and postoperative PSA value was 
3.7 ng/mL (0.3 - 24.8) and 1.9 ng/mL (0.2 - 11.0) 
respectively. While patients from group 2 and 3 
presented a significant drop in PSA levels (p = 0.003 
and p = 0.002 respectively), patients from Group 1 
did not show a significant variation in PSA levels (p = 
0.694). Median postoperative PSA levels were 2.4 (0.2 
- 11.0), 1.4 (0.4 - 5.9) and 1.15 (0.3 - 5.4) for patients 
from Group 1, 2 and 3 respectively (Figure-4). Blood 
transfusions were not required in any group.
COMMENTS
 The present study demonstrated that the 
amount of resected tissue seems to have little impact 
on the short-term clinical outcome after TURP. Al-
Figure 1 – Variation in quality of life (QoL) according to percentage of resected tissue.
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though patients who had more than 50% of the pros-
tatic tissue resected presented a significantly greater 
decrease in QoL score when compared to patients in 
Group 1, both groups presented a significant decrease 
when analyzed individually. Variations in IPSS were 
also slightly greater among patients from Group 3, but 
this figure was not statistically significant. Nocturia 
was not influenced by the PRT.
 Despite the proven efficacy of TURP, the 
question of how much prostatic tissue should be 
resected has existed for more than 70 years. While 
McCarthy stated in 1931 that resection of median 
and lateral lobes should be performed until a free 
view into the bladder was obtained, Blandy stated in 
1978 that total resection of the adenoma inside the 
surgical capsule between the bladder neck and the 
verumontanum was necessary (12).
 The recommended TURP technique  consists 
of complete removal of the entire adenoma inside the 
surgical capsule (5). However, when performed in 
Figure 3 – Variation of nocturia according to percentage of resected tissue.
Figure 2 – Variation of International Prostate Symptom Score (IPSS) according to percentage of resected tissue.
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medically compromised elderly patients with large 
prostates, this procedure may be associated with 
troublesome bleeding and irrigating fluid absorption 
leading to TURP syndrome. Data from 3861 consecu-
tive patients with BPH who underwent TURP from 
1971 to 1996 demonstrated that mortality, morbidity, 
and blood transfusions were observed in 0.1%, 13.4% 
and 13.1% patients, respectively. The most signifi-
cant risk factors for blood transfusion were related 
to resection time, the amount of tissue resected, age, 
and the decade in which the surgery was performed 
(6). Regarding TURP syndrome, Mebust et al. (14), 
showed that its incidence was greater in resections 
lasting longer than 90 minutes and in those producing 
more than 45 grams of tissue. In the present series, 
25% of the patients had more than 50% of the pros-
tates resected, and no case required blood transfusions 
or developed TURP syndrome.
 To date, there is still no consensus regarding 
the amount of prostatic tissue that should be resected 
during TURP. Despite the initial recommendations 
by Nesbit (5), historical data has shown that the 
amount of resected tissue has decreased significantly 
over time (7,8). In the study of Borth et al. (7), mean 
weight of tissue resected in 1988 was 16.5g and 
decreased to 12.5g in 1998. In the series of Vela-
Navarrete et al. (8), mean volume resected in 1992 
was 35.7 mL and decreased to 24.3 mL in 2002. In 
the series of Green et al. (15), which analyzed 432 
patients who underwent TURP, the mean weight of 
tissue resected was 25.6 g and no surgeon resected 
more than 50% of the gland volume. In the present 
series the mean resected tissue weight was 22.3 ± 10.2 
grams, which corresponded to a mean 42% of PRT.
 Data analyzing the outcome of patients who 
underwent complete or partial TURP have led to con-
troversial results. In the study of Chen et al. (9), these 
authors found a good relationship between residual 
prostate weight ratio (weight after TURP divided by 
the preoperative prostate weight) and clinical outcome 
variables among 40 patients who underwent TURP 
and were followed-up for 16 weeks. Their results 
suggest that the better clinical results after TURP 
correlate significantly with the completeness of the 
resection of the obstructing adenoma.
 Conversely, Aagaard et al. (11) prospectively 
assessed the long-term results of total TURP and mini-
mal TURP in 167 patients with obstructive symptoms 
caused by BPH and found that a significant relief in 
obstructive and irritative symptoms was observed in 
both groups. Maximum flow rate and post-void re-
sidual urine improvement were also similar between 
the groups. Similarly, more recently, Agrawal et al. 
(12), in a prospective and randomized study compared 
the hemiresection (complete resection of one lateral 
lobe and the median lobe, if present) of the prostate 
to the standard TURP. They found that the 2 groups 
had comparable improvement in symptom scores and 
Figure 4 – Variation in PSA according to percentage of resected tissue.
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flow rates. Two patients required blood transfusions 
and two developed TURP syndrome in the standard 
resection group and no complications were observed 
in the hemiresection group.
 PSA behavior after TURP is crucial during 
patient follow-up and a subsequent rise in PSA may 
indicate prostate biopsy. Studies have shown that 
PSA decreases drastically in patients who undergo 
TURP. Fonseca et al. (16), showed that mean PSA 
levels declined 71% after TURP, and 60 days after 
surgery the reduction reached its peak, stabilizing 
afterwards. Mean PSA varied from 6.1 ng/mL before 
surgery to 1.7 ng/mL after 60 days postoperatively. In 
the present series we demonstrated that the amount 
of resected tissue might significantly influence PSA 
reduction. Variation in PSA among patients who had 
less than 30% of prostate resected was not significant 
and median postoperative PSA in this group was 2.4 
ng/mL (0.2 - 11.0). Urologists must take into account 
the PRT when analyzing the serum PSA in patients 
who have undergone TURP.
 Some methodological limitations of the pres-
ent study must be considered. We did not analyze 
LUTS function through objective measurements 
such as flow rates or residual urine. According to the 
American Urological Association guidelines these are 
optional assessments for patients with BPH who are 
candidates for surgical treatment (17). Follow-up was 
limited, however, the scope of the study was to assess 
symptom relief and previous data have suggested that 
no further symptom improvement would be observed 
after 3 months of TURP (10). Finally, prostate volume 
was measured by suprapubic rather than transrectal 
ultrasound. However, while the transuretral route is 
considered to be more accurate in prostate size deter-
mination, similar limitations exist for both methods 
(18).
CONCLUSIONS
 Resection of less than 30% of prostatic tis-
sue seems to be sufficient to alleviate LUTS related 
to BPH. However, these patients may not show a 
significant decrease in the serum PSA level. Analysis 
of PSA in men who have undergone TURP must take 
into account the PRT. Patients with more than 50% 
of resected tissue may present a greater variation in 
QoL scores.
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EDITORIAL COMMENT
 Antunes and coauthors investigated the 
impact of the percent of resected tissue (PRT) on 
the improvement of lower urinary tract symptoms 
(LUTS). They found that resection of less than 30% 
of prostatic tissue was sufficient to alleviated LUTS 
although a significant variation on PSA levels was 
not observed in this group. From the perspective of 
subjective outcome, the authors’ observations indicate 
that symptom improvement can be achieved regard-
less of the PRT.
 I do not believe that LUTS is always due to 
enlarged prostate. I do believe that LUTS does not 
need to always be related to prostate enlargement. 
For example, Asian men have a similar frequency 
of prostatic obstruction and more severe symptoms 
despite having a smaller prostate volume (1,2). Thus, 
there is some reason in authors’ results. However, 
since the authors could not provide objective data such 
as maximum flow rate, post-void residual, frequency-
volume charts, it is unknown whether these objective 
parameters may also be improved regardless of the 
PRT. In addition, we cannot know the lower limit of 
PRT for alleviating LUTS based on authors’ results. 
Furthermore, although TURP is a truly ablative pro-
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EDITORIAL COMMENT
 In this paper Antunes et al. address the cor-
relation between the amount of resected tissue during 
transurethral resection of the prostate (TURP) for 
benign prostatic hyperplasia (BPH) and the outcome 
of the procedure. Their conclusions are that “resec-
tion of less than 30% of prostatic tissue seems to be 
sufficient to alleviate lower urinary tract symptoms 
(LUTS) related to BPH”.
 On one hand, our classical idea of TURP is 
as much as complete removal of adenomatous tissue, 
mimicking an open simple prostatectomy, especially 
when operating on healthy patients without high sur-
gical risk. On the other hand, the concept by Antunes 
et al. might sound really appealing because it obvi-
ously means reduced operative time and operative 
risks, as we all know that complications of TURP 
are related to the duration of the procedure, and it 
also means expanding indications of TURP to larger 
prostates.
 However, we think that their final message 
can be misleading and the results have to be criti-
cally analyzed as the study suffers from some major 
methodological flaws.
 Regarding the study rationale: how can you 
offer patients a procedure that is planned as “incom-
plete” from the beginning; how do you inform the 
patients, in this series who are not too old and probably 
have a low ASA score, about the procedure ?
 The authors divided their patients in 3 cohorts 
according to the amount of resected tissue. Unfortu-
nately, from a methodological point of view, this was 
the result of a retrospective analysis, while they ought 
to stratify and then randomize the patients preopera-
tively. Moreover, the operator should know exactly 
when to stop before beginning the procedure not while 
operating. As no selection criteria are reported one can 
imagine that the operator decided arbitrarily to stop 
the resection based on personal experience. However, 
TURP is the gold standard in surgical treatment of 
BPH because the technique has been standardized 
following specific anatomic landmarks so that results 
among different centers can be compared.
 Which patient would benefit from a less than 
30% TURP? Will we ever be able to understand when 
30% (of adenomatous tissue or of the whole gland?) 
has been resected? How will we teach trainees to stop 
cedure for obstruction, authors did not perform pres-
sure-flow studies. Thus, we do not know how many 
patients who have detrusor underactivity or bladder 
outlet obstruction were included in this study.
 In summary, the value of the findings of 
Antunes and co-authors remain unknown. Therefore, 
further studies are needed to answer the question 
about the PRT for the improvement of LUTS/BPH 
and its possible mechanism.
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resection in order to gain good functional results? 
In our personal experience we had, of course, cases 
where we had to stop resecting because extensive 
blood loss or general perioperative complications 
occurred. And most of them functionally did fairly 
well afterwards.
 As recognized by the authors themselves, 
objective outcome parameters, i.e. maximum urinary 
flow rate (Qmax) and post voiding residual urine vol-
ume (PRV), are missing here. Actually, it is suggested 
by some authors that a pressure/flow study had to be 
done when acting within the framework of a clinical 
trial. Moreover, the follow-up (3 months) is really too 
short here (also considering from current literature 
long-term data are already available for TURP). And 
the problem is not that, as the authors commented, “no 
further improvement might be observed…”. In con-
trast, a worsening of the symptoms can be observed. 
That is why long-term data are needed when evaluat-
ing any new minimally invasive surgical procedure 
for BPH treatment.
 In conclusion, we completely agree that “for 
the patient the most important parameter is satisfac-
tion with the symptomatic improvement”. This is the 
reason why we will continue to perform and to teach 
a complete TURP until a reproducible “mini-TURP” 
technique is established.
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